Updated Viloxazine Pharmacology: Experiments Establish Norepinephrine Transporter Occupancy and Serotonin 5-HT2C, 5-HT2B, and 5-HT7 Receptor Binding at Therapeutically Relevant Concentrations.

Saved in:
Bibliographic Details
Title: Updated Viloxazine Pharmacology: Experiments Establish Norepinephrine Transporter Occupancy and Serotonin 5-HT2C, 5-HT2B, and 5-HT7 Receptor Binding at Therapeutically Relevant Concentrations.
Authors: Garcia-Olivares J; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA. jgarciaolivares@supernus.com., Yegla B; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA., Koch J; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA., Yu C; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA., Rubin J; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA.
Source: Drugs in R&D [Drugs R D] 2026 Mar; Vol. 26 (1), pp. 129-139. Date of Electronic Publication: 2026 Apr 03.
Publication Type: Journal Article
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100883647 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-6901 (Electronic) Linking ISSN: 11745886 NLM ISO Abbreviation: Drugs R D Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1179-6901
DOI:10.1007/s40268-026-00543-y